Calian Group (TSE:CGY – Get Free Report) received a C$100.00 target price from stock analysts at Stifel Nicolaus in a report released on Wednesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective points to a potential upside of 23.08% from the company’s current price.
CGY has been the topic of a number of other reports. Ventum Financial boosted their price objective on Calian Group from C$84.00 to C$94.00 and gave the company a “buy” rating in a research note on Tuesday, March 10th. ATB Cormark Capital Markets boosted their price objective on Calian Group from C$92.50 to C$98.50 and gave the company an “outperform” rating in a research note on Tuesday. Canaccord Genuity Group boosted their price objective on Calian Group from C$63.00 to C$80.00 in a research note on Friday, February 13th. Acumen Capital boosted their price objective on Calian Group from C$70.00 to C$85.00 and gave the company a “buy” rating in a research note on Friday, February 13th. Finally, Royal Bank Of Canada boosted their price objective on Calian Group from C$78.00 to C$90.00 and gave the company an “outperform” rating in a research note on Friday, May 15th. Eight investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of C$87.94.
Get Our Latest Research Report on CGY
Calian Group Stock Performance
Calian Group (TSE:CGY – Get Free Report) last announced its quarterly earnings data on Thursday, May 14th. The company reported C$1.30 earnings per share (EPS) for the quarter. Calian Group had a return on equity of 10.35% and a net margin of 3.97%.The business had revenue of C$228.70 million for the quarter. Analysts predict that Calian Group will post 4.9475219 EPS for the current year.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.
Featured Stories
- Five stocks we like better than Calian Group
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
- The Great AI Rotation: Cashing In on Data
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.
